Verdiva Bio, a London-based biotech, has raised an extraordinary US$410m in its oversubscribed Series A round, making it potentially the largest Series A ever raised by a U.K.-based biotech company, according to CEO Khurem Farooq.
https://european-biotechnology.com/wp-content/uploads/2024/04/VC_money.jpg8531280Georg Kääb/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngGeorg Kääb2025-01-09 10:15:042025-01-09 10:51:46USD410m Mega Series A for yet another GLP-1 play?
A US$67.5m Series B financing in XyloCor Therapeutics led by French Jeito Capital will fund two double-blind Phase 2 trials for XC001, a pioneering gene therapy for severe cardiovascular disease.
https://european-biotechnology.com/wp-content/uploads/2025/01/home-img-e1736329790543.jpg540962Christian Kähler/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngChristian Kähler2025-01-09 10:05:412025-01-09 12:39:45Jeito Capital leads $67.5m Series B financing for cardiovascular gene therapy
The aim of this unique initiative, part of the so-called Generation Study, is to sequence the genomes of 100,000 newborns in England to enable the early detection of over 200 selected conditions and to accelerate the treatment of rare diseases.
WuXi Biologics has agreed to sell its Dundalk vaccine manufacturing facility to Merck, a move that will enhance asset efficiencies and allow the company to focus on CDMO services at its other global sites.
https://european-biotechnology.com/wp-content/uploads/2025/01/wuxi-biologics-buffer-prep-room.jpg540960Anette Mertens/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngAnette Mertens2025-01-07 17:26:002025-01-08 13:12:50WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Orbis Medicines secures €90m in Series A funding to accelerate the development of oral macrocycle drugs, leveraging automated chemistry and machine learning.
https://european-biotechnology.com/wp-content/uploads/2024/12/Weihnachten-2024.jpg.webp8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-12-23 08:59:292024-12-23 08:59:29Merry Christmas and a Happy New Year
In parallel with the expansion of its collaboration with SK Bioscience Co. Ltd, the French pharmaceutical company Sanofi SA has announced Phase III testing of its licensed pneumococcal conjugate vaccine PCV21.
https://european-biotechnology.com/wp-content/uploads/2024/12/SK-Bioscience-scaled-e1734938427279.jpg9171570Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-12-23 08:47:382024-12-23 08:47:38Sanofi expands collaboration with SK Bioscience
https://european-biotechnology.com/wp-content/uploads/2025/01/EB.com_Darren_Verlenden_CEO-Single_Use_Support.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2024-12-20 15:27:452025-01-29 08:46:16New CEO completes management team
Screening a library of 712 market-approved drugs, German researchers have found that a cough medicine most efficiently reduced incurable lung fibrosis in mice and in vitro.
LAB Automation – The Society for Laboratory Automation and Screening (SLAS) is transforming the global life sciences community by uniting interdisciplinary researchers and technology providers to drive innovation in laboratory automation and research.
USD410m Mega Series A for yet another GLP-1 play?
Latest NewsVerdiva Bio, a London-based biotech, has raised an extraordinary US$410m in its oversubscribed Series A round, making it potentially the largest Series A ever raised by a U.K.-based biotech company, according to CEO Khurem Farooq.
Jeito Capital leads $67.5m Series B financing for cardiovascular gene therapy
Latest NewsA US$67.5m Series B financing in XyloCor Therapeutics led by French Jeito Capital will fund two double-blind Phase 2 trials for XC001, a pioneering gene therapy for severe cardiovascular disease.
Qiagen joins Newborn genomic screening of NHS
Latest NewsThe aim of this unique initiative, part of the so-called Generation Study, is to sequence the genomes of 100,000 newborns in England to enable the early detection of over 200 selected conditions and to accelerate the treatment of rare diseases.
WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Latest NewsWuXi Biologics has agreed to sell its Dundalk vaccine manufacturing facility to Merck, a move that will enhance asset efficiencies and allow the company to focus on CDMO services at its other global sites.
Orbis Medicines secures €90m to advance oral macrocycle drugs
Latest NewsOrbis Medicines secures €90m in Series A funding to accelerate the development of oral macrocycle drugs, leveraging automated chemistry and machine learning.
Merry Christmas and a Happy New Year
Latest NewsThank you for a successful 2024!
Sanofi expands collaboration with SK Bioscience
Latest NewsIn parallel with the expansion of its collaboration with SK Bioscience Co. Ltd, the French pharmaceutical company Sanofi SA has announced Phase III testing of its licensed pneumococcal conjugate vaccine PCV21.
New CEO completes management team
AppointmentsKufstein-based Single Use Support appointed Darren Verlenden as CEO and strengthens leadership team.
Cough medicine reverses fibrosis in animal models
Latest NewsScreening a library of 712 market-approved drugs, German researchers have found that a cough medicine most efficiently reduced incurable lung fibrosis in mice and in vitro.
Revolutionising research
AssociationsLAB Automation – The Society for Laboratory Automation and Screening (SLAS) is transforming the global life sciences community by uniting interdisciplinary researchers and technology providers to drive innovation in laboratory automation and research.